Yüklüyor......
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status
SARS-CoV-2 is causing an increasing number of deaths worldwide because no effective treatment is currently available. Remdesivir has shown in vitro activity against coronaviruses and is a possible antiviral treatment for SARS-CoV-2 infection. This prospective (compassionate), open-label study of rem...
Kaydedildi:
| Yayımlandı: | Pharmacol Res |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier Ltd.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7212963/ https://ncbi.nlm.nih.gov/pubmed/32407959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2020.104899 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|